Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2013-06-15 17:46:47 UTC |
---|
Update Date | 2023-02-21 17:30:05 UTC |
---|
HMDB ID | HMDB0060602 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | N-acetyl-5-aminosalicylic acid |
---|
Description | N-acetyl-5-aminosalicylic acid is a metabolite of mesalazine. Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is an anti-inflammatory drug used to treat inflammatory bowel disease, such as ulcerative colitis and mild-to-moderate Crohn's disease. Mesalazine is a bowel-specific aminosalicylate drug that acts locally in the gut and has its predominant actions there, thereby having few systemic side effects. (Wikipedia) |
---|
Structure | CC(=O)NC1=CC=C(O)C(=C1)C(O)=O InChI=1S/C9H9NO4/c1-5(11)10-6-2-3-8(12)7(4-6)9(13)14/h2-4,12H,1H3,(H,10,11)(H,13,14) |
---|
Synonyms | Value | Source |
---|
N-Acetyl-5-aminosalicylate | Generator | 5-Acetylaminosalicylate | HMDB | N-Acetyl-5-aminosalicylic acid, monosodium salt | HMDB | N-Acetyl-5-aminosalicylic acid | MeSH |
|
---|
Chemical Formula | C9H9NO4 |
---|
Average Molecular Weight | 195.1721 |
---|
Monoisotopic Molecular Weight | 195.053157781 |
---|
IUPAC Name | 5-acetamido-2-hydroxybenzoic acid |
---|
Traditional Name | 5-acetamido-2-hydroxybenzoic acid |
---|
CAS Registry Number | 51-59-2 |
---|
SMILES | CC(=O)NC1=CC=C(O)C(=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H9NO4/c1-5(11)10-6-2-3-8(12)7(4-6)9(13)14/h2-4,12H,1H3,(H,10,11)(H,13,14) |
---|
InChI Key | GEFDRROBUCULOD-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as acylaminobenzoic acid and derivatives. These are derivatives of amino benzoic acid derivatives where the amine group is N-acylated. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Acylaminobenzoic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Acylaminobenzoic acid or derivatives
- Acetanilide
- Hydroxybenzoic acid
- Salicylic acid
- Salicylic acid or derivatives
- Benzoic acid
- N-acetylarylamine
- Anilide
- Benzoyl
- N-arylamide
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Acetamide
- Vinylogous acid
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Hydrocarbon derivative
- Organic nitrogen compound
- Organic oxide
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-acetyl-5-aminosalicylic acid,1TMS,isomer #1 | CC(=O)NC1=CC=C(O[Si](C)(C)C)C(C(=O)O)=C1 | 2103.2 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,1TMS,isomer #2 | CC(=O)NC1=CC=C(O)C(C(=O)O[Si](C)(C)C)=C1 | 2051.9 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,1TMS,isomer #3 | CC(=O)N(C1=CC=C(O)C(C(=O)O)=C1)[Si](C)(C)C | 1980.7 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TMS,isomer #1 | CC(=O)NC1=CC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1 | 2110.4 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TMS,isomer #2 | CC(=O)N(C1=CC=C(O[Si](C)(C)C)C(C(=O)O)=C1)[Si](C)(C)C | 1984.3 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TMS,isomer #3 | CC(=O)N(C1=CC=C(O)C(C(=O)O[Si](C)(C)C)=C1)[Si](C)(C)C | 1934.5 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1)[Si](C)(C)C | 2002.6 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1)[Si](C)(C)C | 2062.7 | Standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)=C1)[Si](C)(C)C | 2089.3 | Standard polar | 33892256 | N-acetyl-5-aminosalicylic acid,1TBDMS,isomer #1 | CC(=O)NC1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O)=C1 | 2376.5 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,1TBDMS,isomer #2 | CC(=O)NC1=CC=C(O)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2346.1 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,1TBDMS,isomer #3 | CC(=O)N(C1=CC=C(O)C(C(=O)O)=C1)[Si](C)(C)C(C)(C)C | 2241.8 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TBDMS,isomer #1 | CC(=O)NC1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2629.9 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TBDMS,isomer #2 | CC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O)=C1)[Si](C)(C)C(C)(C)C | 2484.5 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,2TBDMS,isomer #3 | CC(=O)N(C1=CC=C(O)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2406.0 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TBDMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2636.7 | Semi standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TBDMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2624.1 | Standard non polar | 33892256 | N-acetyl-5-aminosalicylic acid,3TBDMS,isomer #1 | CC(=O)N(C1=CC=C(O[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)=C1)[Si](C)(C)C(C)(C)C | 2498.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-acetyl-5-aminosalicylic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-1900000000-788568304a3fcb1212fc | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-acetyl-5-aminosalicylic acid GC-MS (2 TMS) - 70eV, Positive | splash10-00e9-4092000000-adfef2d04d46a30ddaf2 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-acetyl-5-aminosalicylic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-acetyl-5-aminosalicylic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid LC-ESI-QFT , negative-QTOF | splash10-0udi-0900000000-1e2f1bce4213b28a08b1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid LC-ESI-QFT , positive-QTOF | splash10-004s-0900000000-3d690c93bc0cd137133a | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 35V, Negative-QTOF | splash10-0udi-0900000000-1e626a1ea4a9d218625a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 35V, Positive-QTOF | splash10-004s-0900000000-09ddbe27b47765828bdf | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 20V, Positive-QTOF | splash10-002r-0900000000-efb5e2918aaffb85b7c0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 10V, Positive-QTOF | splash10-002b-0900000000-5a8bb7813f5fead99f64 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 30V, Positive-QTOF | splash10-000i-0900000000-1a846d2e9239182a9278 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 40V, Positive-QTOF | splash10-000i-0900000000-bf8e0d2800b3ac3084f8 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 10V, Positive-QTOF | splash10-0udj-0900000000-2502f94152ad7435d799 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 20V, Positive-QTOF | splash10-0udi-0900000000-8fe82461a601d6889e09 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 40V, Positive-QTOF | splash10-0zgi-3900000000-b44f554108b57c1c658e | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 10V, Negative-QTOF | splash10-0f6x-0900000000-1be3bca40296d0ac1b39 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 20V, Negative-QTOF | splash10-0udi-0900000000-60d134a7eebe401ea035 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 40V, Negative-QTOF | splash10-0a4i-2900000000-bc8a4061be51b5a858b0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 10V, Positive-QTOF | splash10-0f9j-0900000000-6fd2e59833a14933fdb8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 20V, Positive-QTOF | splash10-000i-0900000000-4dc8b12a502c6b8d9ab8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 40V, Positive-QTOF | splash10-0a4l-8900000000-cd2a7e9d392ad30f3b04 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 10V, Negative-QTOF | splash10-0udl-0900000000-b80ce383de5e955e2409 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 20V, Negative-QTOF | splash10-0zfr-0900000000-92302fe30467bdc8a2e8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-acetyl-5-aminosalicylic acid 40V, Negative-QTOF | splash10-0a59-0900000000-05197b74499be813eb5e | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
---|
Disease References | Irritable bowel syndrome |
---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
| Ulcerative colitis |
---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
|
|
---|